Ensysce Biosciences Inc (ENSC) 13F Positioning & Ownership Changes (Q2 2026)

ENSC ranks #8651 out of 37503 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

ENSC is a disclosed holding of Jane Street (Jane Street Group), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

18 institutions disclose a position in ENSC, but none treat it as a major bet — even Jane Street Group, LLC, its most concentrated holder, allocates just 0.0% of its own portfolio to it.

Adage Capital Partners Gp, L.l.c. has trimmed its ENSC position for two straight quarters, cutting it by $94.3K while still holding $43.4K.

ENSC reported a net loss of $12.6M over the trailing twelve months.

• Not yet profitable — net loss of $12.6M over the trailing twelve months
• Revenue declined 39.3% year over year
• Net income declined year over year, from -$6.6M to -$12.6M
• Operating cash flow was negative, using $7.8M in cash
• Current ratio of 1.59x — enough short-term assets to cover short-term liabilities
• Liabilities run 9951.48x equity — a highly leveraged balance sheet worth noting